| Updated in 5/23/2018 5:51:49 PM |
Viewed: 214 times |
(Journal Article) |
Canadian HIV/AIDS policy & law review 8 (3): 62 (2003)
UK: Hemophiliac wins access to recombinant factor VIII.
Jennifer Gold
ABSTRACT
On 17 July 2003, the England and Wales High Court granted a hemophiliac leave to appeal a decision to refuse to provide him with recombinant factor VIII, a treatment for hemophilia not derived from human blood. The applicant had been infected with HIV and hepatitis B, C, and G through tainted blood products.